Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Aurobindo Pharma Ltd.
NSE: AUROPHARMA
|
BSE: 524804
|
ISIN: INE406A01037
|
Industry: Pharmaceuticals
Analyst Upgrade
|
Mid-range Performer
1205.9000
41.50
(
3.56
%)
NSE
May 12, 2025
15:54 PM
Volume:
2.4M
High volume today
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Aurobindo Pharma Ltd.
23 Aug 2023
Analyst Upgrade
1205.90
3.56%
AUROBINDO PHARMA LTD
Hold:
Aurobindo Pharma Ltd.
by
Geojit BNP Paribas
Target: 915
Recommendation
Target
Geojit BNP Paribas
Number of FII/FPI investors decreased from 730 to 724 in Mar 2025 qtr
More from Aurobindo Pharma Ltd.
Recommended
Which stocks did superstar investors buy in Q4FY25?
The Baseline |
12 May 2025, 04:25PM
Market closes higher, Triveni Turbine's Q4 net profit grows 23.6% YoY to Rs 93.9 crore
Trendlyne Marketwatch |
12 May 2025, 04:03PM
A deal is called off, increasing the chance for Aurobindo Pharma to be debt free
|
15 Jul 2020